Quarterly EPS earnings growth: Exagen (XGN)

Exagen Inc. (XGN) - corporate logo

Exagen Inc. relies on a robust California-based laboratory equipped with backup power supplies. However, slow insurance approvals for tests and promotion costs are weighing on margins. The quarterly EPS growth trend visualizes these processes, with the metric value standing at 17.70. The integration of biomarkers into the AVISE system is transforming the company into a key diagnostic hub for autoimmune pathologies.

XGN: exagen.com Year-over-year earnings per share growth for the last 12 months 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for exagen.com (XGN)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Exagen Inc.
Flagship merchandise of Exagen Inc.

Quarterly EPS growth measures the dynamics of net income per share, reflecting the efficiency of cost management relative to revenue. For Exagen Inc. (XGN), this metric confirms success in monetizing highly specialized diagnostics for autoimmune pathologies. By analyzing the current quarterly EPS growth rate, an investor sees the result of digital transformation and the expansion of the partner network. The positive trend indicates the scalability of the business model, which confirms the fundamental stability of the company.

Key competitors

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MDxHealth MDXH|LUCD: Year-over-year earnings per share growth for the last 12 months|PRE - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics Inc)|TRIB: Quarterly EPS earnings growth|prophaselabs.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HSCS (Heart Test Laboratories Inc.)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months